Amedisys, Inc.
AMED
$100.99
$0.010.01%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 4.92% | 5.34% | 5.01% | 4.19% | 2.70% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 4.92% | 5.34% | 5.01% | 4.19% | 2.70% |
Cost of Revenue | 6.49% | 7.28% | 6.84% | 5.33% | 2.37% |
Gross Profit | 2.93% | 2.92% | 2.71% | 2.76% | 3.13% |
SG&A Expenses | 1.50% | 1.72% | 1.29% | 1.72% | 1.64% |
Depreciation & Amortization | 5.36% | 3.40% | 1.41% | -6.69% | -13.28% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.61% | 5.13% | 4.67% | 3.85% | 1.94% |
Operating Income | 8.09% | 7.49% | 8.55% | 7.82% | 10.93% |
Income Before Tax | 3.96% | 367.30% | 117.59% | 160.12% | 195.27% |
Income Tax Expenses | 30.16% | 21.38% | -4.95% | 3.53% | 9.61% |
Earnings from Continuing Operations | -10.82% | 501.81% | 448.96% | 5,101.32% | 6,566.88% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 1,987.78% | 576.90% | 326.32% | -77.98% | -81.11% |
Net Income | -6.91% | 536.28% | 543.53% | 3,031.95% | 3,847.77% |
EBIT | 8.09% | 7.49% | 8.55% | 7.82% | 10.93% |
EBITDA | 8.34% | 7.75% | 8.62% | 7.92% | 10.63% |
EPS Basic | -7.34% | 531.57% | 539.66% | 2,967.59% | 3,586.13% |
Normalized Basic EPS | 20.59% | 12.11% | 13.24% | 5.66% | 7.18% |
EPS Diluted | -8.16% | 516.32% | 508.16% | 3,749.92% | 4,218.39% |
Normalized Diluted EPS | 20.48% | 11.74% | 12.81% | 4.87% | 6.46% |
Average Basic Shares Outstanding | 0.39% | 0.37% | 0.37% | 0.37% | 0.39% |
Average Diluted Shares Outstanding | 0.47% | 0.65% | 0.72% | 1.09% | 1.02% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |